258 filings
Page 3 of 13
8-K
2c9 yp56n
4 May 22
GBT Reports First Quarter 2022 Financial Results
4:09pm
DEFA14A
t1s2d2qjmnigvuhe9
28 Apr 22
Additional proxy soliciting materials
4:14pm
DEFA14A
j4cve3cvmhip1k3cdbv
28 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
tl96ourzeatdopiy2nrp
25 Mar 22
Departure of Directors or Certain Officers
4:03pm
8-K
y1q9pi8quku6x
23 Feb 22
GBT Reports Fourth Quarter and Full Year 2021 Financial Results
4:07pm
8-K
bdxdy81oqvfg tm3w8mo
16 Feb 22
European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
6:02am
S-8
a80q9bm3vugpxa9
31 Jan 22
Registration of securities for employees
4:51pm
8-K
a16y6
27 Jan 22
Other Events
6:10am
8-K
ndl89cbw4f9hsi2ss
10 Jan 22
Other Events
8:02am
8-K
0auoil
17 Dec 21
Entry into a Material Definitive Agreement
5:09pm
8-K
wggxz0
17 Dec 21
New dispersible tablet dosage form also approved
2:38pm
8-K
s7ku6r4iv h9y0i5jd
17 Dec 21
European Commission decision on marketing authorization anticipated first quarter of 2022
11:14am
8-K
hdbfut3w1v
15 Dec 21
GBT Announces Proposed Offering of $250.0 Million of Convertible Senior Notes
4:23pm
8-K
7rzafqffk
14 Dec 21
Entry into a Material Definitive Agreement
7:17am
8-K
jlaunvarpm2qrtq
13 Dec 21
Other Events
1:11pm
8-K
o4k6zlio7ypkux5a
13 Dec 21
Other Events
9:01am